Privia Health Group (Privia Health Group) 3-Year EPS without NRI Growth Rate : 28.20% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Privia Health Group 3-Year EPS without NRI Growth Rate?

Privia Health Group's EPS without NRI for the three months ended in Dec. 2023 was $0.15.

During the past 3 years, the average EPS without NRI Growth Rate was 28.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 6 years, the highest 3-Year average EPS without NRI Growth Rate of Privia Health Group was 28.20% per year. The lowest was -293.60% per year. And the median was -132.70% per year.

Competitive Comparison of Privia Health Group's 3-Year EPS without NRI Growth Rate

For the Health Information Services subindustry, Privia Health Group's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Privia Health Group's 3-Year EPS without NRI Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Privia Health Group's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Privia Health Group's 3-Year EPS without NRI Growth Rate falls into.

Privia Health Group 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

Privia Health Group (NAS:PRVA) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.

Privia Health Group 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Privia Health Group's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Privia Health Group (Privia Health Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Privia Health Group Inc (NAS:PRVA) » Definitions » 3-Year EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

950 N. Glebe Road, Suite 700, Arlington, VA, USA, 22203

Website

https://www.priviahealth.com

Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.

Executives

William M Sullivan	director	ONE PENN PLAZA, SUITE 5300, NY NY 10119
Thomas Bartrum	officer: EVP, General Counsel	950 N. GLEBE RD., SUITE 700, ALEXANDRIA VA 22203
Pamela O Kimmet	director	11207 ORANGE HIBISCUS LANE, PALM BEACH GARDENS FL 33418
David S Wichmann	director	BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752
Parth Mehrotra	officer: President and COO	950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Adam Boehler	director	1215 5TH AVE N,, NASHVILLE TN 37208
Matthew Shawn Morris	director, officer: Chief Executive Officer	950 N. GLEBE ST., SUITE 700, ARLINGTON VA 22203
Goldman Sachs Group Inc	10 percent owner	200 WEST STREET, NEW YORK NY 10282
Jeffrey Daniel Bernstein	director	200 WEST STREET, NEW YORK NY 10282
Pamplona Capital Partners Iii, L.p.	10 percent owner	94 SOLARIS AVENUE, CAMANA BAY, P.O. BOX 1348, GRAND CAYMAN E9 KY1-1108
Mbd Advisors, L.l.c.	10 percent owner	200 WEST STREET, NEW YORK NY 10282
David Mountcastle	officer: Chief Financial Officer	950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Jeffrey B Butler	director	950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22101
David P King	director	PRIVIA HEALTH GROUP, INC., 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Patricia Anne Maryland	director	7342 HORIZON DRIVE, WEST PALM BEACH FL 33412